BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38664179)

  • 1. Voided urine cytology is a useful tool predicting non-muscle-invasive bladder cancer risk before surgery.
    Gómez Del Cañizo C; González Ginel I; Martín-Arriscado Arroba C; de la Calle Moreno A; Hernández Arroyo M; Rodríguez Antolín A; Guerrero Ramos F
    Urol Oncol; 2024 Apr; ():. PubMed ID: 38664179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of urinary nuclear matrix protein-22 and bladder tumour antigen tests with voided urinary cytology in detecting and following bladder cancer: the prognostic value of false-positive results.
    Poulakis V; Witzsch U; De Vries R; Altmannsberger HM; Manyak MJ; Becht E
    BJU Int; 2001 Nov; 88(7):692-701. PubMed ID: 11890239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of positive urine cytology on progression and cancer-specific mortality of non--muscle-invasive bladder cancer.
    Koga F; Kobayashi S; Fujii Y; Ishioka J; Yokoyama M; Nakanishi Y; Matsuoka Y; Numao N; Saito K; Masuda H; Kihara K
    Clin Genitourin Cancer; 2014 Jun; 12(3):e87-93. PubMed ID: 24169493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The performance of the Xpert Bladder Cancer Monitor Test and voided urinary cytology in the follow-up of urinary bladder tumors.
    Smrkolj T; Cegovnik Primozic U; Fabjan T; Sterpin S; Osredkar J
    Radiol Oncol; 2020 Dec; 55(2):196-202. PubMed ID: 33764701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of telomerase activity and matrix metalloproteinase-9 in voided urine and bladder wash samples as a useful diagnostic tool for bladder cancer.
    Eissa S; Labib RA; Mourad MS; Kamel K; El-Ahmady O
    Eur Urol; 2003 Dec; 44(6):687-94. PubMed ID: 14644121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.
    Blick CG; Nazir SA; Mallett S; Turney BW; Onwu NN; Roberts IS; Crew JP; Cowan NC
    BJU Int; 2012 Jul; 110(1):84-94. PubMed ID: 22122739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary MicroRNAs as Potential Markers for Non-Invasive Diagnosis of Bladder Cancer.
    Erdmann K; Salomo K; Klimova A; Heberling U; Lohse-Fischer A; Fuehrer R; Thomas C; Roeder I; Froehner M; Wirth MP; Fuessel S
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of urinary molecular markers in bladder cancer.
    Eissa S; Swellam M; el-Mosallamy H; Mourad MS; Hamdy NΜ; Kamel K; Zaglol AS; Khafagy MM; el-Ahmady O
    Anticancer Res; 2003; 23(5b):4347-55. PubMed ID: 14666650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of CD44 and cytokeratin 20 mRNA in voided urine samples as diagnostic tools for bladder cancer.
    Eissa S; Zohny SF; Swellam M; Mahmoud MH; El-Zayat TM; Salem AM
    Clin Biochem; 2008 Nov; 41(16-17):1335-41. PubMed ID: 18804101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
    Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V
    Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of the BTAstat test, NMP22, and voided urine cytology in the detection of primary and recurrent bladder tumors.
    Giannopoulos A; Manousakas T; Mitropoulos D; Botsoli-Stergiou E; Constantinides C; Giannopoulou M; Choremi-Papadopoulou H
    Urology; 2000 Jun; 55(6):871-5. PubMed ID: 10840098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative positive voided urine cytology predicts poor clinical outcomes in patients with upper tract urothelial carcinoma undergoing nephroureterectomy.
    Liu W; Wang Z; Liu S; Yao Y; Liu Y; Zhang G
    BMC Cancer; 2020 Nov; 20(1):1113. PubMed ID: 33198698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can sensitivity of voided urinary cytology or bladder wash cytology be improved by the use of different urinary portions?
    Mungan NA; Kulacoglu S; Basar M; Sahin M; Witjes JA
    Urol Int; 1999; 62(4):209-12. PubMed ID: 10567884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BTA test is superior to voided urine cytology in detecting malignant bladder tumours.
    Heino A; Aaltomaa S; Ala-Opas M
    Ann Chir Gynaecol; 1999; 88(4):304-7. PubMed ID: 10661829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Bard BTA test: its mode of action, sensitivity and specificity, compared to cytology of voided urine, in the diagnosis of superficial bladder cancer.
    Schamhart DH; de Reijke TM; van der Poel HG; Witjes JA; de Boer EC; Kurth K; Schalken JA
    Eur Urol; 1998 Aug; 34(2):99-106. PubMed ID: 9693243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma.
    Badalament RA; Hermansen DK; Kimmel M; Gay H; Herr HW; Fair WR; Whitmore WF; Melamed MR
    Cancer; 1987 Oct; 60(7):1423-7. PubMed ID: 3304614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does voided urine cytology have biological significance?
    Tut VM; Hildreth AJ; Kumar M; Mellon JK
    Br J Urol; 1998 Nov; 82(5):655-9. PubMed ID: 9839579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the diagnostic utility of urinary midkine for the detection of bladder cancer.
    Vu Van D; Heberling U; Wirth MP; Fuessel S
    Oncol Lett; 2016 Nov; 12(5):3143-3152. PubMed ID: 27899974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Validation of the Proenkephalin (
    Han H; Oh TJ; Heo JE; Lee J; Jang WS; Lee SH; Ham WS; Hwang J; An S; Choi YD
    Eur Urol Open Sci; 2024 Apr; 62():99-106. PubMed ID: 38496823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of the BTA TRAK assay and comparison to voided urine cytology and the Bard BTA test in patients with recurrent bladder tumors. The Multi Center Study Group.
    Ellis WJ; Blumenstein BA; Ishak LM; Enfield DL
    Urology; 1997 Dec; 50(6):882-7. PubMed ID: 9426718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.